Thesis (Ph. D.)--Lehigh University, 2006. / Includes vita. Includes bibliographical references (leaves 139-152).

Thesis (Ph. D.)--University of Texas at Austin, 2007. / Vita. Includes bibliographical references.

Title: NMR in magnetic systems Author: Petr Křišťan Department: Department of Low Temperature Physics Supervisor: prof. RNDr. Helena Štěpánková, CSc. Abstract: Magnetically ordered iron oxides, namely magnetite, maghemite, hexagonal ferrite M or system Fe-B, with nano or submicron dimensions of particles are the main subject of study of the presented thesis. The materials were investigated mainly by 57 Fe nuclear magnetic resonance (NMR). The results were thoroughly analyzed and compared with the results obtained by other methods (Mössbauer spectroscopy, ZFC/FC magnetic measurement, X-ray diffraction or TEM). In case of the maghemite nanoparticles a regular distribution of vacancies in octahedral positions was verified by the help of NMR in external magnetic fields and at various temperatures. The experi- mental results were also compared with ab-initio calculations. In thin layers of barium M type hexaferrite, effects of reduced particle size on 57 Fe NMR spectra were observed. The NMR methods were also successfully applied to investigation of system FeMoCuB of amorphous and nanocrystalline ribbons, where 57 Fe NMR was able to resolve formation of different phases in depen- dence on the process of preparation. Due to different NMR excitation condi- tions of signal from strontium M type hexaferrite and maghemite,...

There is a demand for new straightforward approaches for stabilization and solubilization of various nanoparticulate materials in their colloidal form, that pave way for fabrication of materials possessing compatibility with wide range of dispersing media. Therefore in this thesis a new general method to form stable nanocrystals in water and organics using amphiphilic polymers generated through simple and low cost techniques is presented and discussed. Amphiphilic coating agents are formed using thiolated or carboxylated polyethylene glycol methyl ether (mPEG-SH) as a starting material. These materials are available with a wide variety of chain lengths. The method of obtaining of amphiphilic NPs is quite general and applicable for semiconductor CdTe nanocrystals as well as nanoscale noble metal (Au) and magnetic (Fe3O4) particles. This approach is based on anchoring PEG segment to the surface of a nanoparticle to form an amphiphilic palisade. Anchoring is realized via interaction of –SH (for CdTe and Au) or –COOH (in the case of magnetite) functional groups with particle’s surface. The resulting amphiphilicity of the nanocrystals is an inherent property of their surface and it is preserved also after careful washing out of solution of any excess of the ligand. The nanocrystals reversibly transfer between different phases spontaneously, i.e. without any adjustment of ionic strength, pH or composition of the phases. Such reversible and spontaneous phase transfer of nanocrystals between solvents of different chemical nature has a great potential for many applications as it constitutes a large degree of control of nanocrystals compatibility with technological processes or with bio-environments such as water, various buffers and cell media as well as their assembly and self-assembly capabilities.

Iron platinum (FePt) has attracted growing interest because of its high Curie temperature, magneto-crystalline anisotropy and chemical stability. Nanoparticles (NPs) made of this alloy are promising candidates for a wide range of biomedical applications including magnetic separation, magnetic targeted drug delivery, hyperthermia for cancer therapy and also as magnetic resonance imaging (MRI) contrast agents. This thesis presents the synthesis, functionalization and characterization of FePt NPs along with a toxicity study and an investigation into their application as MRI contrast agents. Regarding their synthesis, different approaches have been explored including the co-reduction of Fe and Pt precursors in an aqueous media, the thermal decomposition in a conventional high-boiling solvent such as benzyl ether, and in low-melting organic salts (ionic liquids). The data revealed an inhomogeneous composition distribution of Fe and Pt between particles obtained in aqueous media, due to the iron salts hydrolysis, and a mismatch in the co-reduction kinetic of the two metal precursors. While the iron content in the NPs could be increased by using more hydrolytically stable iron precursors or stronger reducing agents, there are remaining limiting parameters which prevent further Fe content increase in NPs. In contrast, by excluding the water from the reaction system and using a Fe²⁻ iron precursor, homogenous 1:1 Fe to Pt ratio NPs can be obtained through a modified thermal decomposition pathway in benzyl ether. Based on the study of synthesis in this conventional chemical, the potential of ionic liquids (ILs) to be used as novel solvents for FePt NPs synthesis was further explored. It was then demonstrated that ionic liquids (ILs) can not only be used as a solvent for synthesis of FePt NPs, but also can provide an exciting alternative pathway to direct synthesis fct-FePt NPs. In the context of the bioapplication of FePt NPs, a family of FePt NPs was specifically designed to enhance their MRI contrast agents properties. In contrast with previous reports, this thesis demonstrates that FePt NPs can be made non-toxic and provides the first data on their cellular uptake mechanisms. A six times increase in the FePt based T₂ contrast properties compared to clinical iron oxide NPs is reported. The relationship between the MRI contrast properties and the NPs architecture is explored and rationalised as the basis for the design of NPs as enhanced MRI contrast agents. Finally, the first observations of cellular and in vivo MR imaging with FePt NPs is also reported. This study opens the way for several applications of FePt NPs such as regenerative medicine and stem cell therapy, thus providing a bio-platform to develop novel diagnostic and therapeutic agents.

No description available.